Dermatologisch decennium

In the past 10 years, much has changed in dermatology, both organizationally and clinically. A shift from clinical treatment to day treatment and outpatient care can partly be explained by the arrival of small molecules and biologicals for the treatment of psoriasis, atopic eczema and hidradenitis suppurativa. However, clinical admission and day treatment with intensive topical treatment sometimes still offers a solution for some patients. External therapeutics must therefore remain available. For more efficient use of expensive drugs, prospective observational research and therapeutic drug monitoring are indicated. More cancer care is needed due to the increase in e.g. basal cell carcinoma (BCC) and skin cancers, despite the emphasis on prevention and early diagnosis. For high-risk BCC in the face, Mohs micrographic surgery is the most important development. A breakthrough has been achieved with drugs that improve metastatic melanoma survival rates. In the field of phlebology, foam sclerosis and endovenous thermal ablation are now the preferred treatments for truncal varicose veins (varices).

Conflict of interest and financial support: potential conflicts of interest have been reported for this article.